JagsonpalPharma Standalone December 2018 Net Sales at Rs 41.89 crore, up 10.09% Y-o-Y
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
JAGSNPHARM Share Price Discussion
Jagsonpal Pharmaceuticals Ltd.
NSE: JAGSNPHARM | BSE: 507789 | ISIN: INE048B01027 | Sector: Pharmaceuticals and health care
JAGSNPHARM Rating
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)
JAGSNPHARM Share Price *
27.5 +0.5 (1.85%)
* (quote may be delayed)
Find answers to all your questions on live JAGSNPHARM message board: Is JAGSNPHARM buy or sell? Should I buy JAGSNPHARM shares? Why are JAGSNPHARM shares falling? Should I invest in JAGSNPHARM stock?
You can also check JAGSNPHARM share price target recommended by brokerages.
JAGSNPHARM Discussion Forum
@newsbot • Reputation: 2,308
JagsonpalPharma Standalone September 2018 Net Sales at Rs 44.12 crore, up 52.65% Y-o-Y
Like
reply
Reply
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.